Pacific Biosciences Of California (PACB) Total Debt (2010 - 2023)

Pacific Biosciences Of California's Total Debt history runs 13 years deep, the most recent figure standing at $96.2 million for Q3 2023.

• In Q3 2023, Total Debt changed N/A year-over-year to $96.2 million; the TTM figure through Sep 2023 stood at $96.2 million (changed N/A YoY), while the FY2022 annual figure was $172.6 million, up 4316.43% from the prior year.
• Total Debt was $96.2 million for Q3 2023 at Pacific Biosciences Of California, down from $186.3 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $186.3 million in Q2 2023 to a low of $3.9 million in Q4 2021.
• Historically, Total Debt has averaged $109.9 million across 4 years, with a median of $134.4 million in 2022.
• The sharpest annual moves came in 2019 and 2022: Total Debt advanced 7.78% in 2019, then jumped 4316.43% in 2022.
• A 4-year view of Total Debt shows it stood at $15.8 million in 2019, then slumped by 75.27% to $3.9 million in 2021, then surged by 4316.43% to $172.6 million in 2022, then sank by 44.27% to $96.2 million in 2023.
• The last three Total Debt figures came in at $96.2 million (Q3 2023), $186.3 million (Q2 2023), and $184.4 million (Q1 2023), per Business Quant data.